Enhanced production of blood clotting factors and fibrin fabric

Details Enhanced production of blood clotting factors and fibrin fabric Enhanced production of blood clotting factors and fibrin fabric

2003-06-12

2008-08-12

Pryor, Alton (Department: 1616)

Drug, bio-affecting and body treating compositions

Designated organic nonactive ingredient containing other...

Carboxylic acid or salt thereof

C514S785000

Reexamination Certificate

active

07411006

ABSTRACT:
The blood collection, processing and transfer by separation of discrete components containing additional citrate (at least about trisodium citrate 9% w/v) in one or other of collection or processing bag provides for enhanced yield and purity of cryoprecipitate. Inhibiting the activation or denaturation of blood components including blood cells and plasma proteins and with the removal of the activated and denatured components thereby improving safety and efficacy of end products. The inventive process is particularly suited to an improved extraction process to yield concentrated clotting factors from single donors or limited pools without use of chromatography. Following extraction the remaining cryoprecipitate can advantageously be formed into a fibrin fabric used in surgeries and in the treatment of wounds.

REFERENCES:
patent: 5981254 (1999-11-01), Bui-Khac

Affiliated with

Also associated with

Rating

Enhanced production of blood clotting factors and fibrin fabric does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Enhanced production of blood clotting factors and fibrin fabric, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enhanced production of blood clotting factors and fibrin fabric will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3998307